chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6 individuals received a 0.3ml dose of undiluted Pfizer Covid-19 vaccine; 6 individuals received a 0.3ml dose of undiluted Pfizer Covid-19 vaccine; One individual reported a brief period of chills/shakes; One individual reported a brief period of chills/shakes; This is a spontaneous report from a non-contactable Nurse reported for a patient. An elderly male patient of an unspecified age received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Dose: 0.3 mL, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 05Feb2021 (age at vaccination was unknown) as unknown, 0.3 ml single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The facility where the most recent COVID-19 vaccine was administered was Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that 6 individuals received a 0.3ml dose of undiluted Pfizer Covid-19 vaccine. No side effects observed/reported @ 1 hour post-vaccination. One individual reported a brief period of chills/shakes @ 24 hours that quickly resolved. No side effects/adverse effects were observed/reported @ 48 hours post vaccination. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The explicit consent was reported as yes. The outcome of the events chills/shakes was resolved on an unknown date in 2021.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021161826 same reporter/drug and different AE/different patient
Onset of headache with abdominal pain nausea and vomiting. Significant hypertension 180/102, HR 92. EKG performed applied cool compresses allowed to rest in darkened room.  Symptoms improving after 30-60 minutes
The day after 2nd Vaccine, I did have lymph node swelling from my chin to collar bone and specifically Clavicular lymph node on my left side that swelled did not go down. I did reach out to physician after it did not go down after 3 weeks. I saw them in May and I did have an ultrasound that found it was just my lymph node. I was instructed not to get the booster yet from doctor. Currently, I am experiencing the lymph node swelling that is about the the size of a marble it is achy occasionally however it is slowly going down. Now I was recommended to do minimal followup with just watching for more symptoms.
This spontaneous report as received from a registered pharmacist refers to a 57 years old female patient with no pertinent medical history, drug reactions or allergies. The patient was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot # H011049; exp date 25-OCT-2012) on 22-OCT-2012. No other co-suspects were reported. Concomitant medications included: penicillin (unspecified). The pharmacist reported that the patient received a dose of ZOSTAVAX, and "two or three days later" (approximately on 24-OCT-2012) returned to the pharmacy and showed him a reddened area on the injection site. The pharmacist reported that the area was not warm, and not hard, and was about the size of a quarter. The pharmacist could not specify the reason for the patient's penicillin (manufacturer unspecified) therapy. No treatment was given for the event. The outcome of redness area on the injection site the sizes of a quarter was unknown. The relatedness for the reported event was not provided for ZOSTAVAX. Additional information is not expected.
I had an extremely sore throat and diarrhea and stomach pain so I went to an urgent care clinic and tested poditive for COVID-19.  I was prescribed Paxlovid and a Prednezone steroid, cough syrup was prescribed but not taken.  Taste disorder is still present at the rtime of this report
A hard knot formed on her upper arm 11 days after administration of the Prevnar 13 vaccine.
dose administered after published expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after published expiry date) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after published expiry date). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (dose administered after published expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took first dose with no side effects were reported. No concomitant and treatment information were reported by the reporter
ARM PAIN AROUND THE INJECTION SITE; FEELING TIRED; TEMPERATURE OF 99.5 FAHRENHEIT; LYMPH NODES SWOLLEN AND HURT; UNABLE TO WALK; COULD NOT MOVE; COULD NOT BEND; BAD LOWER BACK PAIN RADIATING TO LEGS; This spontaneous report received from a patient concerned a 50 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: thyroid disorder, asthma, sulfa allergy, levaquin allergy, seafood/shellfish allergy, penicillin allergy, non-alcohol user, and non-smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: 07-SEP-2021) dose was not reported, administered on 24-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-AUG-2021, the patient experienced unable to walk. On 24-AUG-2021, the patient experienced could not move. On 24-AUG-2021, the patient experienced could not bend. On 24-AUG-2021, the patient experienced bad lower back pain radiating to legs. On 25-AUG-2021, the patient experienced lymph nodes swollen and hurt. On an unspecified date, the patient experienced arm pain around the injection site, feeling tired, and temperature of 99.5 fahrenheit. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 99.5 F. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from could not move, and could not bend on 27-AUG-2021, and temperature of 99.5 fahrenheit, was recovering from bad lower back pain radiating to legs, had not recovered from lymph nodes swollen and hurt, and the outcome of feeling tired, arm pain around the injection site and unable to walk was not reported. This report was non-serious.
Swollen toe, went to ED. Gout/ trauma ruled out. Treated for toe abscess with 7 day augmentin. Went to podiatry where cyst was drained, suspect ganglion cyst. Patient reports swelling in toe is still there, affects gait.
Severe body pain, shaking, nausea, all over muscle aches, could not move arm with the injection, fever. Flu like symptoms.
Received eggless flu vac on 11/23/16. Came back to clinic (12/15/2016). The night of receiving flu shot she began experiencing coughing wheezing and congestion. There was increase in phlegm prod by day 3 and lot of nasal congestion on which got worse and was still experiencing 12/15. 12/15 has bi-lateral ear congestion with left ear drainage. No cough.
Patient had 1st dose of Shingles vaccine at the pharmacy on 9/15/23.  5 days later noted rash to Left clavicle, then notes lesions to Left neck and shoulder.  Positive myalgia, some headache, ear pain.  Skin very sensitive to the touch.
Arm pain (5 days) Fever (3 days) Fatigue (3 days) Malaise (3 days) Chills (3 days) Headache (4 days)
Significant vertigo began about 6 hours post injection. It has improved but it still bothersome 5 months later.?
Severe chills, shivering, body aches, slight nausea. Extreme fatigue, zero appetite.  Very painful at injection site.  Severe sweating
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 02-DEC-2015, the patient was vaccinated with second of dose improperly stored VAQTA, lot # L028666; expiry date 04-NOV-2016 (dose, route and frequency unspecified). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
We have some Moderna Covid-019 vaccine that was given after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.). In October 2021, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment medications were not provided.  It was reported that there were 4 vials (15 dose) 44 doses. The vial was initially stored in the refrigerator on 24-Sep-2021. Vaccine was administered between 24Oct2021 - 27Oct2021. The vials did not undergo any temperature excursions.   This case was linked to MOD-2021-374648, MOD-2021-374935, MOD-2021-374432 (Patient Link).
Information has been received from a physician concerning a 14 year old female patient with possible allergy to penicillin and erythromycin who on 03-JAN-2007 was vaccinated with a first dose of Gardasil (yeast), lot # 653938/0954F. The patient was not on any medication. On 04-JAN-2007 the patient developed hives. The patient was examined by the physician on 05-JAN-2007. The patient was reported as completely recovered by 06-JAN-2007. Additional information has been requested.
Around the first week of May I was experiencing a stuffy nose. Around the middle of May I felt like it had moved to my throat and something was gagging me. I went to Urgent Care and they tested me for strep. They gave me steroids and a Z-pack. The steroid was injectable. The next morning you feeling okay, but in the evening I went back to Urgent Care because it felt bad again. They gave me 3 more days of prednisone, 20 mg per day. One week later I went to my GP. There was a rash on my neck and my doctor gave me 10 days of Bactrim. On the last day of the medicine, I developed a painful sinus headache. I went back to see my GP 2 days later and they treated me for the sinus pressure/headache. They gave me a prescription for 5 days of another antibiotic. I went back a week later and they stopped giving me antibiotics because it had been 20 days. They told me to get over the counter nose spray and told me to clean my nose with saline. Last week I went to an ENT. They told me to continue with the saline and the nose spray.
"Moderna COVID-19 Vaccine EUA"  12 hours post vaccination, I experience the follow symptoms : Cold sweats, fever, nausea, vomiting, and headache.  These symptoms lasted for 5 hours and were relieved with rest and Tylenol.
She had received a vaccine on 4/6/22 and ever since then her arm has been getting increasingly sore. It started in the shoulder and progressed to the elbow and is now into the forearm. Per her, it is now 4/22/22 almost putting her in tears and she doesn't have full use of her arm because of the pain.
pt cranky, non-stop crying when awake; has had 3 naps; t101; APAP for fever; 26OCT92 feeling much better; crying lasted approx 12 hrs; telephone consult w/pvt MD no interventions;
Patient moved while receiving a flu shot, and the full dose was not delivered, some of the flu shot spilled. The flu shot was administered by Certified pharmacy technician. Then a full dose of the same flu shot was administered by Pharmacist, to ensure patient received a full dose flu shot. Patient was satisfied with receiving a full dose flu shot.
Vaccine 1st dose in right arm. 2 hours after soreness in arm at site, aching throughout body.  8 hours after injection ...  itchy all over body.  Wheezing accompanied the inching.  I took Benadryl just to be safe.  Itching and wheezing went away within 1 and a half hours. Following day aching, lethargic all day and diarrhea  for 2 days now.
Pain, Swelling, heat to area of administration, Tenderness throughout lateral deltoid and axilla.
Vaccinated 10-11-23 at 12:00 Noon, at 12:00 Midnight 10-12-23 experienced fever, chills, temp 100. Given Tylenol. 5:30 AM fever, chills, extreme stomach ache. 7:00 AM received 2 hours of dialysis BP dropped to 80/40, HR 110. 4:00 PM Disorientation, taken to Hospital with what appeared to be septic shock. Given broad spectrum antibiotics. 10-13-23 Infectious disease pulled central port, loss of hemodialysis site in the left arm. 10-14-23 temporary line for dialysis, central line and continued broad spectrum ABX. 10-16-23 Permanent central line placed. Unable to establish line for dialysis. 10-17-23 D/C from hospital.  Consult to Hospital for new dialysis site.
Now I am a sick person, with 12 doctors to see; COVID-19 vaccine caused me to have 3 heart attacks (one was a stemi). I died for 3 minutes and was in a coma for more than two weeks; COVID-19 vaccine caused me to have 3 heart attacks (one was a stemi). I died for 3 minutes and was in a coma for more than two weeks; COVID-19 vaccine caused me to have 3 heart attacks (one was a stemi). I died for 3 minutes and was in a coma for more than two weeks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 31Mar2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1, single), administration date: 10Mar2021, for Covid-19 immunization. The following information was reported: MYOCARDIAL INFARCTION (medically significant, life threatening), ACUTE MYOCARDIAL INFARCTION (medically significant, life threatening), COMA (medically significant, life threatening) all with onset 02Aug2021, outcome "not recovered" and all described as "COVID-19 vaccine caused me to have 3 heart attacks (one was a stemi). I died for 3 minutes and was in a coma for more than two weeks"; ILLNESS (medically significant), outcome "not recovered", described as "Now I am a sick person, with 12 doctors to see". Clinical course: The patient believed that Pfizer COVID-19 vaccine caused the patient to have 3 heart attacks (one was a stemi). Patient reportedly died for 3 minutes and was in a coma for more than two weeks. The patient was a very healthy person before. Now, patient is a sick person, with 12 doctors to see. The patient's first vaccine was 10Mar2021 and the second one was 31Mar2021. Patient's heart attacks started 02Aug.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Swelling arm; swelling and redness in his arm; headache; chills; joint and muscle pain; joint and muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling arm), ERYTHEMA (swelling and redness in his arm), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joint and muscle pain) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swelling arm), ERYTHEMA (swelling and redness in his arm), HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint and muscle pain) and MYALGIA (joint and muscle pain). At the time of the report, PERIPHERAL SWELLING (Swelling arm), ERYTHEMA (swelling and redness in his arm), HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint and muscle pain) and MYALGIA (joint and muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Laboratory details were provided. No Treatment information reported.      Reporter did not allow further contact
On 01/30 rash (raised, tiny, red, bumps) started on lower back then progressed up back and down buttocks over 1 day. As week progressed 01/31-02/01 spread to front arms, legs, neck and became more uncomfortable. Chill reported sore and no itching. skin also looked very dry. No fever. Mom states rash gone by 02/06-02/07, but skin still feels dry.
SkinRash, Rash, UrticariaPruritus, swollen submandibular glands Narrative:  Other Relevant History:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Feb2021 as dose 1, single (Lot number: en6201), in left arm, on 04Mar2021 as dose 2, single (Lot number: en6205), in left arm and on 24Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 45 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: Other medical history: Asthma. There were no concomitant medications. The following information was reported: COVID-19 (medically significant) with onset 01May2022, outcome "unknown", DRUG INEFFECTIVE (medically significant) with onset 11May2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06May2022) Negative, notes: testing negative at the end of paxlovid treatment on Friday 06May2022; (11May2022) Positive, notes: I tested highly positive today again today 11May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Developed nausea vomiting and diarrhea on 2 Feb 2003.  Evaluated in clinic on 3 Feb 2003 and received 3 liters of IV fluids for dehydration.  Returned to work on 4 Feb 2003.  Family members were ill with AGE on 1 Feb 2003. BP 140/70, pulse 90
Muscle spasm, pain hands and upper limbs, stiffness same areas; last about 1 week
Shot given in left arm above elbow. Bell's Palsy- no treatment. Eye fluttering Tues on left. Headache behind left ear Wed and continuing. Left side Palsy Fri-Sat and continuing a week later headache radiating down left side of neck. As of yet recovery unknown.
Breakthrough case admission after 2 vaccines  Moderna 5/4/21 lot# 024C21A;  Moderna 6/1/21 lot# 050C21A
Within an hour, I started getting a dry throat and had a dry cough for a few days. A little breathing problem - it was almost like my reaction to bees that I had before - where my throat was closing up but that was just for about an hour. The second day, I had also (three days) of really bad diarrhea.
vision got really blurry,light headed, nauseated, low b/p, runny nose, abdominal pain, weight loss
AT SITE OF INJECTION SLIGHT PINK/RED COLOR 3INX4IN AREA, SWELLING, WARM TO THE TOUCH.
5/29/07 infant received first set of immunizations. well exam-noting improved eczema with vaseline ointment and occ. 1% hydrocortisone cream.  On 5/30/07 Father and grandmother took the child to an urgent care center c/o "rash all over."  Rash was described as diffuse erythematous macular rash with a significant amount of erythema on the feet and in the lower extremities with angioedema that was present. No other abnormalities reported.  Paternal grandmother thought she noticed increase redness and hive looking areas on chest the evening of his immunizations (5/29) but did not report.
suffering from difficult covid symptoms; suffering from difficult covid symptoms; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP), Program ID: (005570). The reporter is the parent.  A 45-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "suffering from difficult covid symptoms". Clinical course: The patient double Pfizer vaccinated and boosted was in his 3 month of suffering from difficult COVID symptoms. Since withheld recently opened its borders there were no long COVID clinics and inadequate medical expertise. He'd just to speak with someone knowledgeable and perhaps got some advice for managing the difficult days.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
a wheel appeared at the injection site.; HCP reporting PROQUAD was accidentally administered intradermally instead of subcuta; This spontaneous report was received from a registered nurse and refers to a male child (age reported as 2 or 4 years old). The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported.  On 29-JUN-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (dose, vaccination scheme, lot #, and expiry date were not provided) administered intradermally instead of subcutaneously, for prophylaxis (Incorrect route of product administration). It was reported the injection was administered at "a very shallow", about 15 degree angle.  On 29-JUN-2022, a wheel appeared at the injection site (Vaccination site urticaria). On the same day the patient recovered form the event.  The causality assessment between the event and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was not provided.
SWEATS, HEADACHE,BODY ACHES,CHILLS,TEMP .OF 101.1 ,
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 07-DEC-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # L002310 exp date 08-JUL-2016) (dose and route not reported). The temperature and time of excursion was 1.11 degrees C for 208 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Swollen lower lip and tongue 15 minutes after shot. Benadryl every 12 hours is managing the situation